We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$321M
AUM Growth
-$12M
Cap. Flow
+$1.48M
Cap. Flow %
0.46%
Top 10 Hldgs %
72.64%
Holding
50
New
7
Increased
14
Reduced
7
Closed
11

Top Buys

Rank Stock Value
1
SIMO icon
Silicon Motion
SIMO
+$21.5M
2
ARQ icon
Arq
ARQ
+$14.8M
3
INFN
Infinera Corporation Common Stock
INFN
+$13.1M
4
ELUT icon
Elutia
ELUT
+$4.1M
5
BDSX icon
Biodesix
BDSX
+$3.51M

Top Sells

Rank Stock Value
1
OUST icon
Ouster
OUST
+$14.7M
2
HUMA icon
Humacyte
HUMA
+$6.71M
3
FENC icon
Fennec Pharmaceuticals
FENC
+$6.34M
4
ALIM
Alimera Sciences
ALIM
+$5.93M
5
OSPN icon
OneSpan
OSPN
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 35.92%
2 Technology 20.02%
3 Industrials 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XAIR icon
26
Beyond Air
XAIR
$4.71M
$1.96M 0.61%
9,097
-189
-2% -$94.1K
GRCE
27
Grace Therapeutics
GRCE
$34.2M
$1.88M 0.59%
641,083
+143,724
+29% +$433K
INAB icon
28
IN8bio
INAB
$9.35M
$1.8M 0.56%
70,933
-24,899
-26% -$799K
FKWL icon
29
Franklin Wireless
FKWL
$27M
$1.42M 0.44%
390,000
– –
KPRX icon
30
Kiora Pharmaceuticals
KPRX
$10.9M
$1.07M 0.33%
255,561
+5
+0% +$23
ZVRA icon
31
Zevra Therapeutics
ZVRA
$610M
$890K 0.28%
+181,673
New +$861K
PSTV
32
DELISTED
Plus Therapeutics
PSTV
$836K 0.26%
+22,747
New +$1.12M
SMTK
33
SmartKem
SMTK
$3.57M
$772K 0.24%
+134,687
New +$898K
ZVRA icon
34
CALL
Zevra Therapeutics
ZVRA
$610M
$674K 0.21%
+137,600
New +$652K
CGTX icon
35
Cognition Therapeutics
CGTX
$88.2M
$499K 0.16%
300,766
-1,596,507
-84% -$3.18M
BFRI icon
36
Biofrontera
BFRI
$15.7M
$450K 0.14%
501,434
– –
EVOK
37
DELISTED
Evoke Pharma
EVOK
$448K 0.14%
70,547
– –
VCNX
38
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$424K 0.13%
108,958
+50,593
+87% +$305K
SVREW
39
SaverOne 2014 Ltd Warrant
SVREW
$35.5K 0.01%
568,194
– –
ADVM
40
DELISTED
Adverum Biotechnologies
ADVM
– –
-162,547
Closed -$2.3M
BWAY
41
Brainsway
BWAY
$642M
– –
-485,872
Closed -$1.29M
HELP
42
Cybin Inc
HELP
$571M
– –
-122,399
Closed -$1.85M
FENC icon
43
Fennec Pharmaceuticals
FENC
$349M
– –
-570,332
Closed -$6.34M
HUMA icon
44
Humacyte
HUMA
$194M
– –
-2,155,958
Closed -$6.71M
DFSC
45
DEFSEC Technologies
DFSC
$3.71M
– –
-2,390
Closed -$630K
DFSCW
46
DEFSEC Technologies Warrant
DFSCW
– –
-598,500
Closed -$77.8K
MU icon
47
CALL
Micron Technology
MU
$1.01T
– –
-260,000
Closed -$30.7M
OSPN icon
48
OneSpan
OSPN
$602M
– –
-500,000
Closed -$5.82M
OUST icon
49
Ouster
OUST
$3.18B
– –
-1,857,114
Closed -$14.7M
ALIM
50
DELISTED
Alimera Sciences
ALIM
– –
-1,520,359
Closed -$5.93M
1
2

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $737M AUM 17.98% 1-Year Est. Return

AIGH Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, AIGH Capital Management held 50 positions worth $321M, down 3.6% from $333M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

AIGH Capital Management's Q2 2024 filing shows 7 new, 14 increased, 7 reduced and 11 closed positions. Its largest new stake was Silicon Motion: 275,000 shares worth $22.3M. The largest sale was Ouster, an estimated $14.7M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.

  • AIGH Capital Management's largest Q2 2024 buy was Silicon Motion: 275,000 shares worth $22.3M.
  • AIGH Capital Management added most to Infinera Corporation Common Stock in Q2 2024, an estimated $13.1M increase.
  • AIGH Capital Management's biggest Q2 2024 reduction was Electrovaya, cutting an estimated $4.69M.
  • AIGH Capital Management fully exited Ouster in Q2 2024, selling an estimated $14.7M.
  • AIGH Capital Management's ten largest holdings make up 73% of its $321M portfolio in Q2 2024.
  • AIGH Capital Management opened 7 new positions and closed 11 in Q2 2024.
  • AIGH Capital Management's portfolio value fell 3.6% quarter-over-quarter to $321M.

Based on AIGH Capital Management's 13F filing for Q2 2024, filed 7 Aug 2024.